MeadowBrook Investment Advisors’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$186K Buy
2,680
+680
+34% +$44.9K 0.15% 110
2026
Q1
$138K Sell
2,000
-902
-31% -$70.5K 0.12% 128
2025
Q4
$256K Sell
2,902
-15
-0.5% -$1.28K 0.22% 94
2025
Q3
$243K Sell
2,917
-70
-2% -$6.1K 0.21% 93
2025
Q2
$279K Sell
2,987
-78
-3% -$7.39K 0.25% 85
2025
Q1
$324K Buy
3,065
+170
+6% +$17.5K 0.3% 74
2024
Q4
$280K Hold
2,895
0.25% 90
2024
Q3
$286K Sell
2,895
-635
-18% -$58.1K 0.26% 82
2024
Q2
$303K Hold
3,530
0.29% 80
2024
Q1
$267K Sell
3,530
-320
-8% -$24.7K 0.25% 88
2023
Q4
$292K Buy
+3,850
New +$269K 0.28% 80

Other funds holding MMSI

MeadowBrook Investment Advisors's MMSI Position: Q2 2026 in Review

MeadowBrook Investment Advisors increased its Merit Medical Systems (MMSI) stake by 34% in Q2 2026, buying an estimated $44.9K and bringing the position to 2,680 shares worth $186K. The position accounts for 0.15% of the portfolio, ranked #110.

MeadowBrook Investment Advisors first reported a position in MMSI in Q4 2023 and has held it in 11 quarters since. The position peaked at $324K in Q1 2025. 405 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • MeadowBrook Investment Advisors held 2,680 shares of Merit Medical Systems worth $186K as of Q2 2026.
  • MeadowBrook Investment Advisors bought 680 Merit Medical Systems shares in Q2 2026, an estimated $44.9K.
  • Merit Medical Systems made up 0.15% of MeadowBrook Investment Advisors's portfolio in Q2 2026, its #110 holding.
  • MeadowBrook Investment Advisors first reported a position in Merit Medical Systems in Q4 2023 and has held it in 11 quarters since.
  • MeadowBrook Investment Advisors's Merit Medical Systems position peaked at $324K in Q1 2025.
  • 405 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on MeadowBrook Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.